Major depression
RecruitingA study to evaluate the effectiveness and safety of DT-101 in adults with major depressive disorder
- Disease:Major depression
- Substances:–
Czechia- Participants:18–64 years · 65+ years
- Sponsor:Draig Therapeutics Limited
Rare diseases
Investigational molecules
Locations
Back to Czechia4 clinical trials in Ricany, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)
Czechia
Czechia
Czechia
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Ongoing clinical trials focusing on schizophrenia treatment and cognitive enhancement. Research evaluates the long-term safety profile of novel therapeutic agents for patients experiencing cognitive impairments.
Extended monitoring of patients who previously participated in phase III clinical programs, emphasizing safety and cognitive outcomes.
Investigation into innovative treatments for osteoarthritis of the knee, specifically targeting chronic pain management and mobility improvement.
Research focuses on evaluating new therapeutic approaches for patients suffering from persistent knee pain due to osteoarthritis.
Tell us about your condition – we search every trial in Europe and connect you with the right site.